Effects of alkyl amine carboxyboranes on L1210 DNA fragmentation and nucleic acid metabolism

Archiv der Pharmazie

Volumn 331, Issue 5, 1998, Pages 153-162

  Miller III, Merrill C ^a   Sood, Anup ^b   Spielvogel, Bernard F ^b   Hall, Iris H ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b Boron Biologicals Inc   (United States)

Author keywords

Amine carboxyboranes; Anti neoplastic agents; DNA topoisomerase II inhibitors; Purine synthesis inhibitors

Indexed keywords

ANTINEOPLASTIC AGENT; BORANE DERIVATIVE; CARBOXY(TRIMETHYLAMINO)BORANE; CYTOTOXIC AGENT; DIMETHYLAMINE CARBOXYBORANE; ISOPROPYLAMINE CARBOXYBORANE; METHYLAMINE CARBOXYBORANE; N BUTYLAMINE CARBOXYBORANE; N PROPYLAMINE CARBOXYBORANE; PYRIDINE CARBOXYBORANE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DEATH; DNA DEGRADATION; DNA SYNTHESIS; DRUG EFFECT; EHRLICH ASCITES TUMOR; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; BORANES; CARBOXYLIC ACIDS; DNA FRAGMENTATION; DNA, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LEUKEMIA L1210; MALE; MICE; RATS; TUMOR CELLS, CULTURED;

EID: 0031809041     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4184(199805)331:5<153::AID-ARDP153>3.0.CO;2-7     Document Type: Article

References (48)

1. I.H. Hall, C.O. Starnes, B.F. Spielvogel, P. Wisian-Neilson, M.K. Das, L. Wojnowich, J. Pharm. Sci. 1979, 68, 685-688.
2. I.H. Hall, C.J. Gilben, A.T. McPhail, K.W. Morse, K. Hassett, B.F. Spielvogel, J. Pharm. Sci. 1985, 74, 755-758.
3. B.F. Spielvogel, A. Sood, I.H. Hall, R.G. Fairchild, P.L. Micca, Strahlenther. Onkol 1989, 165, 123-125.
4. I.H. Hall, D.J. Reynolds, J. Chang, B.F. Spielvogel, T.S. Griffin, Arch. Pharm. (Weinheim) 1991, 324, 573-577.
5. I.H. Hall, E.S. Hall, L.K. Chi, M.C. Miller, III, K.F. Bastow, A. Sood, B.F. Spielvogel, Appl. Org. Met. Chem. 1992, 6, 229-239.
6. I.H. Hall, B.F. Spielvogel, A. Sood, Anti-Cancer Drugs 1990, 1, 133-141.
7. C.K. Sood, A. Sood, B.F. Spielvogel, J.A. Yousef, B.S. Burnham, I.H. Hall, J. Pharm. Sci. 1991, 80, 1133-1140.
8. I.H. Hall, E.S. Hall, M.C. Miller, III, A. Sood, B.F. Spielvogel, Amino Acids 1993, 4, 287-302.
9. I.H. Hall, E.S. Hall, L.K. Chi, B.R. Shaw, A. Sood, B.F. Spielvogel, Anti-Cancer Res. 1992, 12, 1091-1098.
10. I.H. Hall, K.W. Morse, B.F. Spielvogel, A. Sood, Anti-Cancer Drugs 1991, 2, 389-399.
11. I.H. Hall, B.F. Spielvogel, A.T. McPhail, J. Pharm. Sci. 1984, 73, 973-77.
12. M.C. Miller, III, J.R. Vance, K.F. Bastow, A. Sood, B.F. Spielvogel, I.H. Hall, Metal Based Drugs 1997, 4, 229-241.
13. M.C. Miller, III, A. Sood, B.F. Spielvogel, I.H. Hall, Res. Commu. Pharm. Toxic. 1996, 1, 245-268.
14. R.J. Geran, N.H. Greenburg, M.M. MacDonald, A.M. Schumacher B.J. Abbott, Cancer Chemother. Rep. 1972, 3, 9-24.
15. A.L. Leibovitz, J.C. Stinson, W.B. McComb, III, C.E. McCoy, K.C. Mazur, N.D. Mabry, Cancer Res. 1976, 36, 4562-4569.
16. L.L. Liao, S.M. Kupchan, S.B. Horwitz, Mol. Pharmacol. 1976, 12, 167-176.
17. E. Cadman, R. Heimer, C. Benz, J. Biol. Chem. 1981, 256, 1695-1704.
18. R.J. Christopherson, M.L.Yu, M.E. Jones, Anal. Biochem. 1981, 11, 240-249.
19. D.C. Eichler, P.A. Fisher, D. Korn, J. Biol. Chem. 1977, 252, 4011-4014.
20. H. Sawada, K. Tatsumi, M. Sadada, S. Shirakawa, T. Nakamura, G. Wakisaka, Cancer Res. 1974, 34, 3341-3346.
21. K.M. Anderson, I.S. Mendelson, G. Guzik, Biochem. Biophys. Acta 1975, 383, 56-66.
22. I.H. Hall, G.L. Carlson, G.S. Abernathy, C. Piantadosi, J. Med. Chem. 1974, 17, 1253-1257.
23. E.G. Moore, R.B. Hurlbert, J. Biol. Chem. 1966, 241, 4802-4809.
24. F. Maley, S. Ochoa, J. Biol. Chem. 1958, 233, 1538-1543.
25. S.M. Kalman, P.H. Duffield, T.J Brzozwki, J. Biol. Chem. 1966, 241, 1871-1877.
26. R.M. Archibald, J. Biol. Chem. 1944, 156, 121-142.
27. S.B. Koritz, P.P. Gohen, J. Biol. Chem. 1954, 209, 145-149.
28. A. Kampf, R.L. Barfknecht, P.J. Schaffer, S. Osaki, M.P. Mertes, J. Med. Chem. 1976, 19, 903-908.
29. Y.K. Ho, T. Hakala, S.F. Zakrzewski, Cancer Res. 1971, 32, 1023-1028.
30. M.K. Spassova, G.G. Russev, E.V. Goovinsky, Biochem. Pharmacol. 1976, 25, 923-924.
31. J.H. Becker, G.W. Lohr, Klein. Wochenschr. 1979, 57, 1109-1115.
32. O.H. Lowry, J. Rosebrough, A.L. Farr, R.J. Randall, J. Biol. Chem. 1951, 193, 265-275.
33. A.S. Bagnara, L.R. Finch, Anal. Biochem. 1971, 45, 24-34.
34. D. Hunting, J.F. Henderson, Can. J. Biochem. 1982, 59, 723-727.
35. H. Suzuki T. Nishimura, S.K. Muto, N. Tanaka, J. Antibacterial. 1978, 32, 875-883.
36. J.F. Pera Sr, C.J. Rawlings, J. Shackleton, J.J. Roberts, Biochem. Biophys. Acta 1981, 655, 152-166.
37. J.W. Woynarowski T.A. Beerman, J. Konopa, Biochem. Pharmacol. 1981, 30, 3005-3007.
38. Y. Zhao, I.H. Hall, C.B. Oswald, T. Yokoi, K.H. Lee, Chem. Phar. Bull. 1987, 35, 2052-2061.
39. L.F. Liu, T.C. Rowe, L. Yang, K.M. Tewey, G.L. Chen, J. Biol. Chem. 1983, 258, 15365-15370.
40. L.F. Liu, J.D. Davis, R. Calendra, Nucleic Acid Res. 1981, 9, 3979-3989.
41. K.G. Miller, L.F. Liu, P.T. Englund, J. Biol. Chem. 1981, 256, 9334-9339.
42. T.C. Rowe, G.L. Chen, Y.H. Hsiang, L.F. Liu, Cancer Res. 1986, 46, 2021-2026.
43. W.O. Harker, D.L. Slade, F.H. Drake, R.L. Parr, Biochemistry 1991, 30, 9953-9961.
44. M.R. Feng, M. Liebert, G. Wedemeyer, H.B. Grossman, W.R. Mancini, M. Williams, J.G. Wagne, Selective Cancer Therapeut. 1991, 7, 75-83.
45. [451 R.F. DeVore, A.H. Corbett, N. Osheroff, Cancer Res. 1991, 52, 2156-2161.
46. M. Chu, G.A. Fischer, Biochem. Pharmacol. 1968, 77, 753-767.
47. A.H. Corbett, A.W. Fernald, N. Osheroff, Biochemistry 1993, 32, 2090-2097.
48. G.A. Hofmann, C.K. Mirabelli, F.H. Drake, Anti-Cancer Drug Design, 1990, 5, 273.